http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004063174-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y406-01001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88 |
| filingDate | 2001-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662978811549d9e89eb02ea1aa55b9cf |
| publicationDate | 2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004063174-A1 |
| titleOfInvention | Regulation of human adenylate cyclase |
| abstract | Reagents which regulate human adenylate cyclase and reagents which bind to human adenylate cyclase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, peripheral and central nervous system disorders, disorders of the genito-urinary system including but not limited to benign prostatic hyperplasia and urinary incontinence, obesity, COPD and diabetes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004060987-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004020993-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114982718-A |
| priorityDate | 2000-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 206.